Therapeutic effect of 7, 3′-dimethoxy hesperetin on adjuvant arthritis in rats through inhibiting JAK2-STAT3 signal pathway

International Immunopharmacology

Volumn 14, Issue 2, 2012, Pages 157-163

  Li, Rong ^a,b   Cai, Li ^a   Ren, Dan Yang ^a,b   Xie, Xue Feng ^a,b   Hu, Cheng Mu ^a,b   Li, Jun ^a,b  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b Key Laboratory for Bioactivity of Natural Medicine of Anhui Province   (China)

Author keywords

7, 3 dimethoxy hesperetin; Adjuvant arthritis; IL 6; JAK2 STAT3 signal pathway

Indexed keywords

7, 3' DIMETHOXY HESPERETIN; ANTIRHEUMATIC AGENT; FREUND ADJUVANT; GLYCOSIDE; HESPERETIN; INTERLEUKIN 6; JANUS KINASE 2; MESSENGER RNA; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANKLE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; MALE; NONHUMAN; PATHOPHYSIOLOGY; PAW EDEMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SYNOVIUM; TRIPTERYGIUM;

ANIMALS; ANKLE JOINT; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; DISEASE MODELS, ANIMAL; DOWN-REGULATION; FREUND'S ADJUVANT; HESPERIDIN; HUMANS; INTERLEUKIN-6; JANUS KINASE 2; MALE; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; SYNOVIAL MEMBRANE;

EID: 84864150240     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2012.07.001     Document Type: Article

References (40)

1. G. Sindhu, M. Ratheesh, G.L. Shyni, B. Nambisan, and A. Helen Anti-inflammatory and antioxidative effects of mucilage of Trigonella foenum graecum (Fenugreek) on adjuvant induced arthritic rats Int Immunopharmacol 12 2012 205 211
2. M. Gadina, D. Hilton, J.A. Johnston, A. Morinobu, A. Lighvani, and Y.J. Zhou Signaling by type I and II cytokine receptors: ten years after Curr Opin Immunol 13 2001 363 373 (Pubitemid 32537710)
3. J.G. Walker, and M.D. Smith The Jak-STAT pathway in rheumatoid arthritis J Rheumatol 32 2005 1650 1653 (Pubitemid 41324798)
4. T. Kisseleva, S. Bhattacharya, J. Braunstein, and C.W. Schindler Signaling through the JAK/STAT pathway, recent advances and future challenges Gene 285 2002 1 24 (Pubitemid 34246317)
5. A.S. de Hooge, F.A. van de Loo, M.I. Koenders, M.B. Bennink, O.J. Arntz, and T. Kolbe Local activation of STAT-1 and STAT-3 in the inflamed synovium during zymosan-induced arthritis: exacerbation of joint inflammation in STAT-1 gene-knockout mice Arthritis Rheum 50 2004 2014 2023 (Pubitemid 38725114)
6. T. Mori, T. Miyamoto, H. Yoshida, M. Asakawa, M. Kawasumi, and T. Kobayashi IL-1beta and TNFalpha-initiated IL-6-STAT3 pathway is critical in mediating inflammatory cytokines and RANKL expression in inflammatory arthritis Int Immunol 23 2011 701 712
7. J.G. Walker, M.J. Ahern, M. Coleman, H. Weedon, V. Papangelis, and D. Beroukas Expression of Jak3, STAT1, STAT4, and STAT6 in inflammatory arthritis: unique Jak3 and STAT4 expression in dendritic cells in seropositive rheumatoid arthritis Ann Rheum Dis 65 2006 149 156 (Pubitemid 43131986)
8. E. Karouzakis, M. Neidhart, R.E. Gay, and S. Gay Molecular and cellular basis of rheumatoid joint destruction Immunol Lett 106 2006 8 13 (Pubitemid 44093056)
9. A. Krause, N. Scaletta, J.D. Ji, and L.B. Ivashkiv Rheumatoid arthritis synoviocyte survival is dependent on Stat3 J Immunol 169 2002 6610 6616 (Pubitemid 36903515)
10. T. Shouda, T. Yoshida, T. Hanada, T. Wakioka, M. Oishi, and K. Miyoshi Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis J Clin Invest 108 2001 1781 1788 (Pubitemid 34015123)
11. J.G. Walker, M.J. Ahern, M. Coleman, H. Weedon, V. Papangelis, and D. Beroukas Changes in synovial tissue Jak-STAT expression in rheumatoid arthritis in response to successful DMARD treatment Ann Rheum Dis 65 2006 1558 1564 (Pubitemid 44799665)
12. H. Jawed, S.U. Shah, S. Jamall, and S.U. Simjee N-(2-hydroxy phenyl) acetamide inhibits inflammation-related cytokines and ROS in adjuvant-induced arthritic (AIA) rats Int Immunopharmacol 10 2010 900 905
13. M. Liu, W. Mao, H. Guan, L. Li, B. Wei, and P. Li Effects of taurochenodeoxycholic acid on adjuvant arthritis in rats Int Immunopharmacol 11 2011 2150 2158
14. D. Wang, Y. Chang, Y. Wu, L. Zhang, S. Yan, and G. Xie Therapeutic effects of TACI-Ig on rat with adjuvant arthritis Clin Exp Immunol 163 2011 225 234
15. L. Zhang, J. Li, S.C. Yu, Y. Jin, X.W. Lv, and Y.H. Zou Therapeutic effects and mechanisms of total flavonoids of Turpinia Arguta Seen on adjuvant arthritis in rats J Ethnopharmacol 116 2008 167 172
16. Y.Q. Zheng, W. Wei, L. Zhu, and J.X. Liu Effects and mechanisms of Paeoniflorin, a bioactive glucoside from paeony root, on adjuvant arthritis in rats Inflamm Res 56 2007 182 188 (Pubitemid 46985833)
17. M. Nazari, A. Ghorbani, A. Hekmat-Doost, M. Jeddi-Tehrani, and H. Zand Inactivation of nuclear factor-kappaB by citrus flavanone hesperidin contributes to apoptosis and chemo-sensitizing effect in Ramos cells Eur J Pharmacol 650 2011 526 533
18. K. Kawaguchi, H. Maruyama, T. Kometani, and Y. Kumazawa Suppression of collagen-induced arthritis by oral administration of the citrus flavonoid hesperidin Planta Med 72 2006 477 479
19. R. Li, J. Li, L. Cai, C.M. Hu, and L. Zhang Suppression of adjuvant arthritis by hesperidin in rats and its mechanisms J Pharm Pharmacol 60 2008 221 228 (Pubitemid 351211838)
20. A. Garg, S. Garg, L.J. Zaneveld, and A.K. Singla Chemistry and pharmacology of the Citrus bioflavonoid hesperidin Phytother Res 15 2001 655 669 (Pubitemid 34016792)
21. L. Peng, Q. Zhang, R. Li, and J. Li Anti-inflammatory activity screening of hesperidin derivatives Acta Univ Med Anhui 46 2011 36 39
22. R. Li, L. Cai, X.F. Xie, L. Peng, and J. Li 7,3′-dimethoxy hesperetin induces apoptosis of fibroblast-like synoviocytes in rats with adjuvant arthritis through caspase 3 activation Phytother Res 24 2010 1850 1856
23. X. Tao, H. Schulze-Koops, L. Ma, J. Cai, Y. Mao, and P.E. Lipsky Effects of Tripterygium wilfordii hook F extracts on induction of cyclooxygenase 2 activity and prostaglandin E2 production Arthritis Rheum 41 1998 130 138 (Pubitemid 28041931)
24. L.L. Zhang, W. Wei, S.X. Yan, X.Y. Hu, and W.Y. Sun Therapeutic effects of glucosides of Cheanomeles speciosa on collagen-induced arthritis in mice Acta Pharmacol Sin 25 2004 1495 1501 (Pubitemid 39490896)
25. J.B. Jiang, J.D. Qiu, L.H. Yang, J.P. He, G.W. Smith, and H.Q. Li Therapeutic effects of astragalus polysaccharides on inflammation and synovial apoptosis in rats with adjuvant-induced arthritis Int J Rheum Dis 13 2010 396 405
26. Q.T. Wang, L.L. Zhang, H.X. Wu, and W. Wei The expression change of beta-arrestins in fibroblast-like synoviocytes from rats with collagen-induced arthritis and the effect of total glucosides of paeony J Ethnopharmacol 133 2011 511 516
27. M. Sasai, Y. Saeki, S. Ohshima, K. Nishioka, T. Mima, and T. Tanaka Delayed onset and reduced severity of collagen-induced arthritis in interleukin-6-deficient mice Arthritis Rheum 42 1999 1635 1643 (Pubitemid 30263631)
28. N. Tastekin, N. Aydogdu, D. Dokmeci, U. Usta, M. Birtane, and H. Erbas Protective effects of l-carnitine and alpha-lipoic acid in rats with adjuvant arthritis Pharmacol Res 56 2007 303 310 (Pubitemid 47488898)
29. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(- Delta Delta C(T)) method Methods 25 2001 402 408 (Pubitemid 34164012)
30. I.B. McInnes, and F.Y. Liew Cytokine networks-towards new therapies for rheumatoid arthritis Nat Clin Pract Rheumatol 1 2005 31 39
31. F.A. Houssiau, J.P. Devogelaer, J. Van Damme, C.N. de Deuxchaisnes, and J. Van Snick \Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides Arthritis Rheum 31 1988 784 788
32. H. Okamoto, M. Yamamura, Y. Morita, S. Harada, H. Makino, and Z. Ota The synovial expression and serum levels of interleukin-6, interleukin-11, leukemia inhibitory factor, and oncostatin M in rheumatoid arthritis Arthritis Rheum 40 1997 1096 1105 (Pubitemid 27242297)
33. S.J. Chung, Y.J. Kwon, M.C. Park, Y.B. Park, and S.K. Lee The correlation between increased serum concentrations of interleukin-6 family cytokines and disease activity in rheumatoid arthritis patients Yonsei Med J 52 2011 113 120
34. R. Madhok, A. Crilly, J. Watson, and H.A. Capell Serum interleukin 6 levels in rheumatoid arthritis: correlations with clinical and laboratory indices of disease activity Ann Rheum Dis 52 1993 232 234 (Pubitemid 23094315)
35. P.C. Heinrich, I. Behrmann, G. Muller-Newen, F. Schaper, and L. Graeve Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway Biochem J 334 Pt 2 1998 297 314 (Pubitemid 28448572)
36. L.B. Ivashkiv, and X. Hu The JAK/STAT pathway in rheumatoid arthritis: pathogenic or protective? Arthritis Rheum 48 2003 2092 2096 (Pubitemid 36959187)
37. J.M. Dayer, and E. Choy Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor Rheumatology (Oxford) 49 2010 15 24
38. J.M. Kremer, R. Blanco, M. Brzosko, R. Burgos-Vargas, A.M. Halland, and E. Vernon Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: results from the double-blind treatment phase of a randomized placebo-controlled trial of tocilizumab safety and prevention of structural joint damage at one year Arthritis Rheum 63 2011 609 621
39. K. Ghoreschi, A. Laurence, and J.J. O'Shea Janus kinases in immune cell signaling Immunol Rev 228 2009 273 287
40. J.S. Fridman, P.A. Scherle, R. Collins, T.C. Burn, Y. Li, and J. Li Selective inhibition of JAK1 and JAK2 is efficacious in rodent models of arthritis: preclinical characterization of INCB028050 J Immunol 184 2010 5298 5307